Studies should focus on elucidating the molecular mechanisms underlying insulin’s influence on skeletal remodeling, including its effects on osteoblast and osteoclast activity, to develop targeted therapies for osteoporosis and metabolic bone diseases. Here, INS is linked to osteoporosis.